ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain"

  • Abstract Number: 0838 • ACR Convergence 2022

    Is SARS-CoV-2 Associated with Worse Outcomes After Total Knee Arthroplasty?

    Lisa Mandl1, Benjamin Swett1, Robyn Lipschultz1, Myriam Lin1, Alison Zhao2, Carola Hanreich1, Dongmei Sun1, Kethy Jules-elysee1 and Friedrich Boettner1, 1Hospital for Special Surgery, New York, NY, 2Cleveland Clinic Lerner College of Medicine, Cleveland, OH

    Background/Purpose: Over 520 million people have been infected by SARS-CoV-2. In 10-40%, disabling symptoms such as fatigue and dyspnea can persist. Risk factors for poor…
  • Abstract Number: 1307 • ACR Convergence 2022

    Effect of Romosozumab in Postmenopausal Women with Knee Osteoarthritis: Results from the FRAME Clinical Trial

    Nancy Lane1, Donald Betah2, Cynthia Deignan2, Mary Oates2, Zhenxun Wang2, Jen Timoshenko3, Aliya Khan4 and Neil Binkley5, 1University of California Davis, Hillsborough, CA, 2Amgen, Inc., Thousand Oaks, CA, 3UCB Pharma, Slough, United Kingdom, 4McMaster University, Oakville, ON, Canada, 5University of Wisconsin, Madison, WI

    Background/Purpose: Osteoarthritis (OA) and osteoporosis (OP) often occur concomitantly in the elderly. The relationship between OA and OP is complex, with increased fracture risk reported…
  • Abstract Number: 1810 • ACR Convergence 2022

    Frequency and Patterns of Opioid Use in the Management of Gout: A Population-Based Study

    Tuhina Neogi1, Martin Englund2, Aleksandra Turkiewicz2 and Ali Kiadaliri2, 1Boston University School of Medicine, Boston, MA, 2Lund University, Lund, Sweden

    Background/Purpose: Treatment guidelines for management of gout do not recommend opioids. We evaluated the frequency of opioid prescriptions in those with gout compared with the…
  • Abstract Number: 1972 • ACR Convergence 2022

    Comprehensive Investigation of Pain and Inflammation in Rheumatoid Arthritis from a Multidisciplinary Approach

    Lilla Tóth1, Gergely Orsi2, Krisztina Csókási3, Gábor Sütő4, Gábor Kumánovics5, Noémi Császár-Nagy6, Szabolcs Takács7, Eszter Szigedi8, Zsófia Nagy8, Zsolt Hodovány8, Lili Duzsik8, Zoltán Vidnyánszky9, József Kun10, Péter Urbán10, György Nagy11 and Zsuzsanna Helyes12, 1Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, Pécs, Hungary, 2MTA-PTE Clinical Neuroscience MR Research Group, Eötvös Loránd Research Network (ELKH); Department of Neurology, Medical School, University of Pecs, Pécs, Hungary, 3Institute of Psychology, Faculty of Humanities and Social Sciences, University of Pécs, Pécs, Hungary, 4Second Department of Medicine and Nephrology-Diabetes Centre, University of Pécs, Pécs, Hungary, 5Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary, 6National University of Public Services; Psychosomatic Outpatient Clinics, Budapest, Hungary, 7Department of Psychology, Karoly Gaspar University, Budapest, Hungary, 8Psychosomatic Outpatient Clinics, Budapest, Hungary, 9Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary, 10Szentágothai Research Centre, Bioinformatics Research Group, Genomics and Bioinformatics Core Facility, University of Pécs, Pécs, Hungary, 11Department of Rheumatology and Clinical Immunology, Department of Internal Medicine and Oncology, Semmelweis University; Department of Genetics, Cell and Immunobiology, Semmelweis University; Heart and Vascular Centre, Semmelweis University, Budapest, Hungary, 12Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs; Szentágothai Research Centre and Centre for Neuroscience, University of Pécs, Pécs, Hungary

    Background/Purpose: Despite the therapeutic advances of rheumatoid arthritis (RA), optimal disease control cannot be achieved in the difficult-to-treat (D2T) RA population, leading to the persistence…
  • Abstract Number: 0206 • ACR Convergence 2022

    Differences in Medicinal Cannabis Use According to Demography, Rationale, and Patient-Physician Interactions Between the United States and Canada

    kevin boehnke1, Ying He1, Tristin Smith1, marc martel2, david williams1 and Mary-Ann Fitzcharles3, 1University of Michigan, Ann Arbor, MI, 2McGill University, Montréal-Ouest, Canada, 3McGill University, Montréal, QC, Canada

    Background/Purpose: Medical cannabis (MC) is increasingly used by persons with rheumatic conditions worldwide, although legal status varies by country. In Canada, MC has been federally…
  • Abstract Number: 0839 • ACR Convergence 2022

    Association of Tibial Acceleration During Walking to Knee Pain and Loading in Adults with Knee Osteoarthritis

    Khara James1, Patrick Corrigan2, Corey Lanois3, Chun-Hao Huang4, Irene Davis5 and Joshua Stefanik4, 1Northeastern Unviersity, Boston, MA, 2Saint Louis University, St. Louis, MO, 3Northeastern University, Providence, RI, 4Northeastern University, Boston, MA, 5University of South Florida, Tampa, FL

    Background/Purpose: Pain and abnormal loading are known to be associated with the progression of knee osteoarthritis (OA). Individuals with knee OA have increased vertical loading…
  • Abstract Number: 1350 • ACR Convergence 2022

    A Prospective Study on Pain Associated with Injection of Needles: PAIN Study

    Chay Bae1, Eugenia Chen1 and Maida Wong2, 1Rheumatology, University of California, Irvine School of Medicine, Irvine, CA, 2Rheumatology, VA Long Beach Healthcare System, Long Beach, CA

    Background/Purpose: Joint pain is a common issue amongst patients. In the appropriate clinical setting, joint injections or aspirations may benefit the patient. Pain, however, is…
  • Abstract Number: 1847 • ACR Convergence 2022

    Differences in Key Patient-reported Outcome Domains Identified by the Patient Acceptable Symptom State in the Adult SAPHO and Chronic Nonbacterial Osteomyelitis Observational Study (The SAPHO-CNO Study)

    Aleksander Lenert1, Robyn Domsic2, Karmela Kim Chan3, Melissa Oliver4, Jisna Paul5, Courtney Kremer6, Emma Leisinger1, Svjetlana Dolovcak7, Sandy D. Hong8, Aruni Jayatilleke9, Petar Lenert7, T. Shawn Sato1, Samir Shah10, Shima Yasin11, Yongdong (Dan) Zhao12, Daniel Solomon13, Jonathan Templin1 and Polly Ferguson11, 1University of Iowa, Iowa City, IA, 2University of Pittsburgh, Pittsburgh, PA, 3Hospital for Special Surgery, New York, NY, 4Indiana University School of Medicine, Indianapolis, IN, 5Ohio State University Hospital, Dublin, OH, 6University of Iowa Stead Family Children's Hospital, Solna, IA, 7University of Iowa Hospitals and Clinics, Iowa City, IA, 8University of Iowa Stead Family Children's Hospital, Iowa City, IA, 9Temple University, PHILADELPHIA, PA, 10Tufts Medical Center, Boston, MA, 11University of Iowa Carver College of Medicine, Iowa City, IA, 12University of Washington, Redmond, WA, 13Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Incorporating patient perspectives of their disease state is needed for disease activity assessment in adults with SAPHO syndrome and chronic nonbacterial osteomyelitis (CNO). The…
  • Abstract Number: 1973 • ACR Convergence 2022

    Association Between Activity Limitations, Sleep Disturbance, Pain Sensitivity, Pain Intensity, and Widespread Pain in Adults with Rheumatoid Arthritis

    Burcu Aydemir1, Jing Song2, Lutfiyya Muhammad3, Daniela Grimaldi1, Kathryn Reid1, Phyllis Zee1, Rowland Chang4 and Yvonne Lee1, 1Northwestern University, Chicago, IL, 2Northwestern University, Evanston, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL, 4Northwestern University Division of Rheumatology, Chicago, IL

    Background/Purpose: Despite treatment with strong immunosuppressive medications, more than half of patients with rheumatoid arthritis (RA) still report pain. Pain can spread from joint sites…
  • Abstract Number: 0297 • ACR Convergence 2022

    Effect of Upadacitinib, Adalimumab, and Placebo on Residual Pain Among Patients with Rheumatoid Arthritis Whose Inflammation Was Attenuated After Three and Six Months of Treatment

    Louis Bessette1, Adriana Kakehasi2, Neil Basu3, David A. Walsh4, Andra Balanescu5, Clifton Bingham6, Andrew Garrison7, Ivan Lagunes8, sander strengholt9, Ralph Lippe10 and Maxime Dougados11, 1Centre de l'Ostoporose et de Rhumatologie de Québec, Québec, QC, Canada, 2Federal University of Minas Gerais, Hospital das Clínicas, Belo Horizonte, Brazil, 3University of Glasgow, Glasgow, Scotland, United Kingdom, 4University of Nottingham, Nottingham, United Kingdom, 5University of Medicine and Pharmacy Carol Davila, Bucharest, Romania, 6Johns Hopkins University, Baltimore, MD, 7AbbVie, Inc., North Chicago, IL, 8AbbVie, Inc., Mettawa, IL, 9AbbVie, Inc., Abcoude, Netherlands, 10AbbVie, Inc, Wiesbaden, Germany, 11Université de Paris, Paris, France

    Background/Purpose: Residual pain remains a challenge that prevents patients (pts) with RA from achieving a better quality of life. Current RA treatments have demonstrated efficacy…
  • Abstract Number: 0849 • ACR Convergence 2022

    The Impact of Diabetes Status on Pain and Disability Following Total Joint Arthroplasty for Hip and Knee Osteoarthritis: Variation by Sex and Body Mass Index

    J Denise Power1, Anthony Perruccio2, J Roderick Davey2, Rajiv Gandhi2, Nizar Mahomed2, Khalid Syed2, Christian Veillette2 and Y Raja Rampersaud2, 1Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 2Schroeder Arthritis Institute, University Health Network; University of Toronto, Toronto, ON, Canada

    Background/Purpose: Hip and knee total joint arthroplasties (TJA) for osteoarthritis (OA) are frequently performed surgical procedures, representing the majority of direct expenditures for OA. TJA…
  • Abstract Number: 1355 • ACR Convergence 2022

    Relationships Between Work Productivity, Activity Impairment, and Select Patient-Reported Outcomes in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of Two Placebo-Controlled Trials

    Marina Magrey1, James Cheng-Chung WEI2, Arne Yndestad3, Andrew Bushmakin4, Joseph Cappelleri4, Oluwaseyi Dina5 and Atul Deodhar6, 1Case Western Reserve University, University Hospitals, Richfield, OH, 2Chung Shan Medical University Hospital, Taichung, Taiwan, 3Pfizer Inc, Oslo, Norway, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, New York, NY, 6Oregon Health & Science University, Portland, OR, USA, Portland, OR

    Background/Purpose: Patients (pts) with AS often experience impaired work productivity.1 In pts with AS receiving tofacitinib (oral Janus kinase inhibitor), improvements were observed in work…
  • Abstract Number: 1885 • ACR Convergence 2022

    Histopathological Patterns of Muscle Involvement and Clinical Correlations in a Retrospective Cohort of Scleroderma Patients

    Noemie Le Gouellec1, Louai Zaidan2, Eric Hachulla3, Nicolas Dognon3, Robin Dhote4, Sebastien Riviere5, Yurdagul Uzunhan4, Luc Mouthon6 and Jerome Authier7, 1CH Valenciennes, Valenciennes, France, 2CHU Henri Mondor, Creteil, France, 3University of Lille, LILLE, France, 4Hopital Avicenne - Paris University, Bobigny, France, 5Hopital Saint Antoine - Paris University, Paris, France, 6Hopital Cochin - Paris University, Paris, France, 7Paris Est - Creteil University, Creteil, France

    Background/Purpose: Muscle involvement in systemic sclerosis (SSc) has been shown to be heterogeneous. Histopathological pattern seems to be associated with prognosis, but studies evaluating the…
  • Abstract Number: 1975 • ACR Convergence 2022

    Identifying MicroRNAs Associated with Neuropathic Pain in Patients with Rheumatoid Arthritis (RA)

    Lissette Delgado-Cruzata1, Milena Rodriguez Alvarez2, Veronika Zenkeviciute3, Nickolas Almodovar3 and Toni-Ann Bravo3, 1City University of New York, New York, NY, 2SUNY Downstate Medical Center, New York, NY, 3John Jay College, CUNY, New York, NY

    Background/Purpose: Neuropathic pain is one of the most common clinical characteristics of rheumatoid arthritis (RA). It often does not subside with the use of DMARD,…
  • Abstract Number: 0371 • ACR Convergence 2022

    A Phase 2, Double-blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101/Lenabasum in Systemic Lupus Erythematosus, an Autoimmunity Centers of Excellence Study (ALE09)

    Meggan Mackay1, Robert Zurier2, Diane Kamen3, Fotios Koumpouras4, Anca Askanase5, Kenneth Kalunian6, Steffan Schulz7, Giovanni Franchin8, Nancy Olsen9, Andreea Coca10, Roberto Caricchio11, Maureen McMahon12, Maria Dall'Era13, Amit Saxena14, Megan Clowse15, Stanley Ballou16, Linna Ding17, Beverly Welch18, Jessica Springer19, Andrew Shaw1, Lynette Keyes-Elstein20, Kaitlyn Steinmiller21, Amanda Mickey21, Cynthia Aranow1 and Betty Diamond1, 1Feinstein Institutes for Medical Research, Manhasset, NY, 2Feinstein Institutes, Wyckoff, NJ, 3Medical University of South Carolina, Charleston, SC, 4Yale School of Medicine, New Haven, CT, 5Columbia University Medical Center, New York, NY, 6University of California San Diego, La Jolla, CA, 7Univ Pennsylvania, Philadelphia, PA, 8BronxCare, Feinstein Institutes, Manhasset, NY, 9Penn State University/Milton S Hershey, Hershey, PA, 10UPMC, Pittsburgh, PA, 11Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 12University of California Los Angeles, Los Angeles, CA, 13University of California, Division of Rheumatology, San Francisco, CA, 14NYU School of Medicine, New York, NY, 15Duke University, Durham, NC, 16Case Western Reserve University - Metro Health, Cleveland, OH, 17NIH NIAID, Rhockvile, MD, 18NIAID/NIH, Bethesda, MD, 19NIH/NIAID, Rockville, MD, 20Rho, Chapel Hill, NC, 21Rho Inc, Durham, NC

    Background/Purpose: Musculoskeletal (MSK) symptoms are common in SLE, often associate with debilitating pain requiring immunosuppressive treatment. JBT-101 is a non-psychotropic, non-immunosuppressive, cannabinoid receptor 2 agonist…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 37
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology